Suppr超能文献

相似文献

2
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension.
Clin Mol Hepatol. 2014 Dec;20(4):376-83. doi: 10.3350/cmh.2014.20.4.376. Epub 2014 Dec 24.
6
Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
J Hepatol. 2009 Aug;51(2):279-87. doi: 10.1016/j.jhep.2009.04.015. Epub 2009 May 24.

引用本文的文献

1
Update on the Complications and Management of Liver Cirrhosis.
Med Sci (Basel). 2025 Feb 5;13(1):13. doi: 10.3390/medsci13010013.
2
Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies.
World J Gastrointest Endosc. 2021 Dec 16;13(12):628-637. doi: 10.4253/wjge.v13.i12.628.
5
Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patients.
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S20-S26.
6
Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.
Hepatol Int. 2018 Feb;12(Suppl 1):112-121. doi: 10.1007/s12072-017-9806-1. Epub 2017 Jul 11.
7
β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis.
World J Gastroenterol. 2015 Jun 21;21(23):7191-6. doi: 10.3748/wjg.v21.i23.7191.
9
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension.
Clin Mol Hepatol. 2014 Dec;20(4):376-83. doi: 10.3350/cmh.2014.20.4.376. Epub 2014 Dec 24.
10
Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
Clin Mol Hepatol. 2012 Jun;18(2):203-12. doi: 10.3350/cmh.2012.18.2.203. Epub 2012 Jun 26.

本文引用的文献

3
Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
Am J Gastroenterol. 2006 Mar;101(3):506-12. doi: 10.1111/j.1572-0241.2006.00453.x.
4
Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis.
J Gastroenterol Hepatol. 2006 Feb;21(2):413-9. doi: 10.1111/j.1440-1746.2005.04071.x.
5
Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study.
World J Gastroenterol. 2005 Dec 28;11(48):7560-3. doi: 10.3748/wjg.v11.i48.7560.
6
[Assessment and current treatment of portal hypertension].
Korean J Hepatol. 2005 Sep;11(3):211-7.
8
Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Am J Gastroenterol. 2005 Mar;100(3):631-5. doi: 10.1111/j.1572-0241.2005.41381.x.
9
Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis.
Korean J Intern Med. 2004 Sep;19(3):165-70. doi: 10.3904/kjim.2004.19.3.165.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验